Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Deciphera Pharmaceuticals, Inc. (DCPH)  
$25.36 0.01 (0.04%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 60,930,000
Market Cap: 1.55(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $10.11 - $25.38
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. In addition, Co. has identified and developed various product candidates from its platform into clinical studies, including vimseltinib and DCC-3116. Co. is studying vimseltinib in a Phase 3 study in patients with tenosynovial giant cell tumor. DCC-3116 is designed to inhibit autophagy, a key tumor survival mechanism in cancer cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 10,000 1,687,666
Total Buy Value $0 $0 $138,828 $30,291,232
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 1 3
Total Shares Sold 10,159 75,715 115,161 179,650
Total Sell Value $158,659 $1,108,986 $1,602,723 $2,646,007
Total People Sold 4 5 6 6
Total Sell Transactions 4 14 25 43
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 290
  Page 10 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Taylor Michael Douglas Director   –       •      –    2019-09-03 4 OE $1.89 $14,175 D/D 7,500 7,500     -
   New Leaf Bpo Associates I, L.p. 10% Owner   –       –       •   2019-08-16 4 S $36.54 $7,334,467 I/I (200,000) 1,963,258     -
   New Leaf Bpo Associates I, L.p. 10% Owner   –       –       •   2019-08-15 4 S $36.09 $5,413,665 I/I (150,000) 2,067,858     -
   Bristol James Arthur Director   –       •      –    2019-08-13 4 AS $39.24 $999,365 D/D (25,000) 0     -
   Bristol James Arthur Director   –       •      –    2019-08-13 4 OE $1.89 $47,250 D/D 25,000 25,000     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2019-08-13 4 AS $42.90 $1,072,500 I/I (25,000) 66,779     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2019-08-13 4 AS $40.26 $4,988,255 D/D (123,107) 24,500     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2019-08-13 4 OE $1.89 $232,672 D/D 123,107 147,607     -
   Taylor Michael Douglas Director   –       •      –    2019-08-13 4 AS $39.47 $917,342 D/D (22,500) 0     -
   Taylor Michael Douglas Director   –       •      –    2019-08-13 4 OE $1.89 $42,525 D/D 22,500 22,500     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-08-13 4 AS $40.69 $464,255 D/D (11,250) 0     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-08-13 4 OE $1.89 $21,263 D/D 11,250 11,250     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-06-19 4 AS $25.00 $4,425 D/D (177) 0     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-06-19 4 OE $1.89 $335 D/D 177 177     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-06-03 4 AS $25.20 $52,927 D/D (2,100) 0     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-06-03 4 OE $1.89 $3,969 D/D 2,100 2,100     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-05-22 4 AS $25.00 $2,500 D/D (100) 0     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-05-22 4 OE $1.89 $189 D/D 100 100     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-05-21 4 AS $25.07 $34,419 D/D (1,373) 0     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-05-21 4 OE $1.89 $2,595 D/D 1,373 1,373     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-05-01 4 AS $22.93 $309,524 D/D (13,500) 0     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2019-05-01 4 OE $1.89 $25,515 D/D 13,500 13,500     -
   Hoerter Steven L. President & CEO   •       •      –    2019-03-18 4 A $0.00 $0 D/D 52,000 52,000     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2019-02-21 4 OE $3.95 $96,775 D/D 24,500 24,500     -
   Taylor Michael Douglas President and CEO   •       •      –    2019-02-19 4 AS $30.00 $119,913 D/D (3,997) 0     -
  290 Records found
  Previous  10  11  12   
  Page 10 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us